Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × HMPL-013 × Clear all

NCT03903705 2025-04-06

: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor